PBE - PBE: Biotech Could Be Next Big Winner
2024-04-01 10:30:00 ET
Summary
- Biotechnology and genomics sector has not performed well in recent years, making it an attractive investment opportunity.
- The Invesco Biotechnology & Genome ETF offers comprehensive exposure to the biotech sector with a diversified portfolio.
- PBE has performed better than some similar ETFs but worse than others, highlighting the importance of stock selection in this sector.
Investing in the field of biotechnology and genomics can be a profitable venture, especially for investors keen on scientific and technological advancements. The problem? It hasn't done well at all in the last couple of years. As a matter of fact, when looking at the entire sector, you'd be hard pressed to call it a bull market. That may be exactly why you want to consider it right now - the fact that it lagged so badly against broad market averages....
PBE: Biotech Could Be Next Big Winner